Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma-Reference-Cited by-同舟云学术

Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma

Published:2012-05-27 Issue:4 Volume:7 Page:363-372
ISSN:1555-4309
Container-title:Contrast Media & Molecular Imaging
language:en
Short-container-title:Contrast Media Mol. Imaging

Author:

Bu Lihong,Xie Jin¹,Chen Kai²,Huang Jing²,Aguilar Zoraida P.³,Wang Andrew³,Sun Kin Wai⁴,Chua Mei-Sze⁴,So Samuel⁴,Cheng Zhen¹,Eden Henry S.¹,Shen Baozhong⁵,Chen Xiaoyuan¹

Affiliation:

1. Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Bethesda; MD; USA

2. Molecular Imaging Program at Stanford, Department of Radiology; Stanford University School of Medicine; Stanford; CA; USA

3. Ocean NanoTech; LLC; Springdale; AR; USA

4. Asian Liver Center, Department of Surgery; Stanford University School of Medicine; Stanford; CA; USA

5. Department of Radiology; the Fourth Hospital of Harbin Medical University; Heilongjiang; China

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Reference23 articles.

1. Iron oxide nanoparticle platform for biomedical applications;Xie;Curr Med Chem,2009

2. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions;Poeckler-Schoeniger;Magn Reson Imag,1999

3. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging - comparison of optimized sequences;Ward;Radiology,2003